COGT
Cogent Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.58B
P/E Ratio
—
EPS
$-2.17
Beta
0.37
52W High
$43.73
52W Low
$4.79
50-Day MA
$35.40
200-Day MA
$29.16
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Cogent Biosciences Inc
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-121.63M |
| EBITDA | $-359.49M |
| Operating Margin | 0.00% |
| Return on Equity | -85.70% |
| Return on Assets | -38.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $3.18 |
| Price-to-Book | 10.28 |
| Price-to-Sales (TTM) | 861.15 |
| EV/Revenue | 929.31 |
| EV/EBITDA | -3.88 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $170.87M |
| Float | $160.86M |
| % Insiders | 0.52% |
| % Institutions | 112.10% |
Historical Volatility
HV 10-Day
43.57%
HV 20-Day
34.86%
HV 30-Day
30.84%
HV 60-Day
43.14%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($54.25 target)
2
Strong Buy9
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026